Indications of Letermovir
Letermovir is a prescription medication used to help prevent cytomegalovirus (CMV) infection and disease in adults at high risk of developing CMV infection and disease who have received an allogeneic hematopoietic stem cell (bone marrow) transplant, as well as CMV disease in adults at high risk of CMV disease who have received a kidney transplant.
Reliable Purchase Channels for Letermovir
Hospital Pharmacies
Letermovir is already marketed in China. Patients can visit a hospital directly for consultation; a doctor will issue a prescription based on the patient’s condition, and the drug can be purchased at the hospital pharmacy.
Online Pharmacies
Some online pharmacies may offer online purchasing services for letermovir. When buying from online pharmacies, be sure to choose trustworthy platforms and ensure the drugs are supplied through formal channels.
Physical Pharmacies
Patients may also purchase letermovir at local licensed physical pharmacies, where a valid medical prescription is usually required before purchase.
Medical Service Institutions
When purchasing letermovir, always follow medical advice and ensure all purchasing activities comply with relevant laws and regulations. As letermovir is a prescription drug, patients must obtain a doctor’s prescription before use.
Use in Special Populations
Pediatric Patients
Adequate studies on the relationship between age and the effects of letermovir have not been conducted in the following pediatric groups, so safety and efficacy have not been established:
Infants below 6 months of age or weighing less than 6 kg who have undergone allogeneic hematopoietic stem cell (bone marrow) transplantation
Children below 12 years of age or weighing less than 40 kg who have undergone kidney transplantation
Geriatric Patients
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the use of letermovir in the elderly.
Breastfeeding Women
Adequate studies in breastfeeding women have not been performed to determine the risk to infants when taking this drug. Before using letermovir while breastfeeding, weigh the potential benefits against the potential risks.
If any abnormal or allergic reactions to letermovir or its ingredients occur, inform your doctor immediately.
